|
Studienakronym |
Krankheitsentität  |
Vollständiger Titel / Beschreibung |
Status |
|
|
TRIO33_NATALEE |
Brustkrebs
|
A phase III, multicenter, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone receptor-positive, HER2-negative, early breast cancer (New Adjuvant TriAl with Ribociclib [LEE011]:
|
 |
 |
|
|
TUD-PEMAZA-068 |
Blutkrebs (z.B. Leukämie, Lymphome)
|
MRD-guided treatment with pembrolizumab and azacitidine in NPM1mut AML patients with an imminent hematological relapse
|
 |
|
|
|
Vaccibody VB N-01 |
Sonst. urogenitale Tumore z.B. Blase,Niere
Sonst. urogenitale Tumore z.B. Blase,Niere
|
An open labelled first human dose phase 1/2a study to evaluate safety, feasibility and efficacy of multiple dosing with individualised VB10.NEO immunotherapy in patients with locally advanced or metastatic melanoma, NSCLC, clear renal cell carcinoma, urothelial cancer or squamous cell carcinoma of head and neck, who did not reach complete responses with current standard of care immune checkpoint blockade
|
|
|
|
|
Varianz |
Magentumor
|
Vorhersage von Ansprechen oder Resistenz durch Identifizierung von Biomarkern beim Adenokarzinom des Magens und des gastroösophagealen Übergangs innerhalb einer nicht-interventionellen Studie und zielgerichteter Therapie mit Trastuzumab
|
|
|
|
|
VB N-01 |
Sonst. urogenitale Tumore z.B. Blase,Niere
Sonst. urogenitale Tumore z.B. Blase,Niere
Krebserkrankungen der Haut
Lungenkrebs
Sonstige Tumore
|
An open labelled first human dose phase 1/2a study to evaluate safety, feasibility and efficacy of multiple dosing with individualised VB10.NEO immunotherapy in patients with locally advanced or metastatic melanoma, NSCLC, clear renal cell carcinoma, urothelial cancer or squamous cell carcinoma of head and neck, who did not reach complete responses with current standard of care immune checkpoint Blockade - Melanom Kohorte geschlossen Z-Nr.: 347 TrackCell Tablets located in III Med Studiensekretariat Second Pharmajet handed over to Urologie Department on 26Sep2019
|
|
|
|
|
VesPa |
Schwindel und Taumel
[R42]
|
Therapie der Vestibularisparoxysmie mit Carbamazepin: eine prospektive randomisierte Placebo-kontrollierte doppelblinde multizentrische Studie
|
|
|
|
|
Vitamin D Vertigo |
Schwindel und Taumel
[R42]
|
Sekundärprophylaktische Behandlung des benignen peripheren paroxysmalen Lagerungsschwindels (BPPV) mit Vitamin D
|
|
|
|
|
VONES100 |
Sonstige Tumore
|
Verlauf und Outcome-Korrelation der glialen Proteine S100? und Neuronen-spezifischer Enolase (NSE) im Blut bei der Bestrahlung von Hirnmetastasen (VONES100)
|
|
|
|
|
WO29636 |
Sonstige Tumore
|
a Phase III, open-Label, multicenter, randomized study of ATEZOLIZUMAB (ANTI-L1 Antibody) versus observation as adjuvant therapy in patients with PD-L1-selected, high-risk muscle-invasive bladder cancer after cystectomy
|
|
|
|
|
WOPP |
Sonstiger Spontanpneumothorax
[J93.1]
|
Pulmonary wedge resection plus parietal pleurectomy (WRPP) versus parietal pleurectomy (PP) for the treatment of recurrent primary pneumothorax (Prospektiv-randomisierte multizentrische klinische Studie zum Vergleich zweier etablierter Operationsmethoden)
|
|
|
|
|
Xolair (Omalizumab) |
Sonstige Studien
-
Idiopathische Urtikaria
[L50.1]
|
A PHASE III; Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study To Evaluate the efficacy and safety of XOLAIR (Omalizumab) in Patients with chronic Idiopathic Urticaria (CIU) Who remain Symptomatic Despite Antihistamine Treatment (H1)
|
|
|
|
|
ZILVERPASS |
Atherosklerose der Extremitätenarterien
[I70.2-]
|
Eine prospektive, multizentrische, randomisierte Studie zur Bewertung der Implantation Medikament-freisetzenden Stents (Cook Zilver PTX) im Vergleich zu einer Bypass-Operation bei Behandlung der femoropoplitealen TASC C & D Läsionen
|
|
|
